ANVS - Annovis Bio, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.64 0.2 (12.2%)	---	---	0.0 (0.0%)	-0.02 (-1.18%)	0.2 (12.35%)	-0.01 (-0.54%)	-0.01 (-0.54%)

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.32
Diluted EPS:: -0.32
Basic P/E:: -5.75
Diluted P/E:: -5.75
RSI(14) 1m:: 100.0
VWAP:: 1.84
RVol:: 0.8188

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.67 -0.02 (-1.15%)	Oct 15 09:38
1m	Price increase 1m	1.67 +0.02 (+1.19%)	Oct 15 09:31
10m	Price increase 10m	1.67 +0.05 (+3.07%)	Oct 15 09:31
1m	Price increase 1m	1.65 +0.02 (+1.54%)	Oct 15 09:30
1m	Price decrease 1m	1.61 -0.03 (-1.83%)	Oct 15 05:08